Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Rochester, NY

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Position Overview

  • Location Type: Territory-Based (Buffalo, NY & Syracuse, NY)
  • Employment Type: Full Time
  • Salary: Not provided in the text
  • Company: Cytokinetics

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. This role focuses on introducing Cytokinetics in a designated territory and launching its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM).

Requirements

  • Education: Bachelor’s Degree required
  • Experience: 5+ years of experience in biotech/pharma sales required
  • Territory Ownership: Experience as a rep with sole ownership of the territory is highly preferred.
  • Specialty Experience (Preferred):
    • Cardiology experience
    • Rare disease experience
    • Specialty product experience
  • Launch Experience (Preferred): Experience with specialty product launches

Responsibilities

  • Sales Performance: Deliver sales results and operate autonomously within the territory.
  • Territory Planning: Develop territory-specific account plans to identify, assess, and prioritize opportunities.
  • Integrated Team Collaboration: Work synergistically with internal stakeholders (medical, payer, patient navigation/support) and external customers.
  • Subject Matter Expert: Serve as a subject matter expert and resource to customers, providing clinically relevant disease and product information.
  • Demand Generation: Create demand for the product launch by effectively communicating approved resources to healthcare professionals (HCPs), including:
    • Marketing materials
    • Payer information
    • Formulary coverage
    • Patient support services
    • Educational programs
  • Strategic Focus: Demonstrate strategic thinking, passion for the company’s core values, and a proactive approach to supporting the company’s mission to address patients’ unmet needs.

Application Instructions

  • Not provided in the text

Company Information

  • Company: Cytokinetics
  • Focus: Specialty cardiovascular biopharmaceutical company developing muscle activators and inhibitors for cardiovascular diseases.
  • Core Values:
    • Patients are our North Star
    • Science is in our Soul
    • We > Me
    • Make it Happen

Skills

Biotech/Pharma Sales
Cardiology
Rare Disease
Specialty Product
Territory Planning
Account Management
Customer Education
Demand Generation
Stakeholder Collaboration

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI